Skip to Content
Søk Menu

ASH2020: Triplet combination in R/R Mantle Cell Lymphoma – New data from the Nordic Lymphoma Group

Få tilgang

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Relatert innhold

Martin Dreyling

ECHO Trial Highlights Acalabrutinib’s Promise in Mantle Cell Lymphoma Treatment

/ Martin Dreyling
ASH24Lymfom Play the Video 03:48

EHA 2024: One of the Most Important for Many Years

/ BestPractice Nordic
EHA24Lymfom
Jelena Jelicic

More Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Can Participate in Clinical Studies

/ Jelena Jelicic
EHA24Lymfom Play the Video 03:34
Ari Melnick

Presidential Symposium: Unmet Needs in the Lymphoma Field

/ Ari M. Melnick
EHA24Lymfom Play the Video 5:11
Ingrid Glimelius

Elderly Patients with Mantle Cell Lymphoma Need to be More Intensively Treated

/ Ingrid Glimelius
EHA24Lymfom Play the Video 1:50
Michael Wang

LBA: Acalabrutinib plus Bendamustine and Rituximab Show Significant Improvement in PFS for Elderly Patients with Mantle Cell Lymphoma

/ Michael Wang
EHA24Lymfom Play the Video 04:08
Patrick Nylund

The Blood Proteome Predicts High Risk of Relapse in Mantle Cell Lymphoma Patients

/ Patrick Nylund
EHA24Lymfom Play the Video 01:57
Ryan Jacobs

EHA24: Updated Results on the AZD-0486 Trial for Treating Relapsed Refractory Follicular Lymphoma

/ Ryan Jacobs
EHA24Lymfom Play the Video 4:48
Cathy Burton

Paradigm Changes in Hodgkin’s Lymphoma Treatments

/ Cathy Burton
ASCO24Hodgkins lymfomLymfom Play the Video 19:00
Back to top